Concord Medical Services Holdings Limited
CCM
$4.30
-$0.01-0.23%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 9.76% | 18.07% | 29.95% | 9.63% | -8.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.76% | 18.07% | 29.95% | 9.63% | -8.00% |
| Cost of Revenue | -5.70% | 2.27% | 13.14% | 10.79% | 9.46% |
| Gross Profit | 52.61% | 45.24% | 36.58% | -15.99% | -158.08% |
| SG&A Expenses | -1.19% | -2.90% | -2.13% | -7.48% | -11.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.01% | 0.30% | 7.20% | 3.36% | 0.61% |
| Operating Income | 16.24% | 15.10% | 11.93% | 2.55% | -9.74% |
| Income Before Tax | 36.60% | 13.59% | -19.09% | -32.54% | -50.33% |
| Income Tax Expenses | 65.53% | -28.14% | -621.17% | -721.25% | -911.70% |
| Earnings from Continuing Operations | 33.98% | 16.00% | -8.41% | -21.90% | -39.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -20.83% | -24.77% | -26.54% | -12.50% | 6.93% |
| Net Income | 41.64% | 9.23% | -45.91% | -56.42% | -69.74% |
| EBIT | 16.24% | 15.10% | 11.93% | 2.55% | -9.74% |
| EBITDA | 23.61% | 23.09% | 18.80% | 7.76% | -6.33% |
| EPS Basic | 41.64% | 47.37% | 49.01% | 46.66% | 43.93% |
| Normalized Basic EPS | -46.49% | -23.51% | -4.80% | -4.80% | -4.81% |
| EPS Diluted | 41.61% | 47.32% | 48.94% | 53.32% | 56.56% |
| Normalized Diluted EPS | -46.49% | -23.51% | -4.80% | -4.80% | -4.81% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
